1 / 5

Using Simulation and Decision Modeling to Inform Decision Making

This Morning's Session. Can Clinical Trials really answer all relevant questions?What if the patient is older/younger/sicker/ better/etc. than in the trials?What if the technology has changed?What if management strategy has changed?Can simulation modeling help fill in the gaps?. From the Modeler

kita
Download Presentation

Using Simulation and Decision Modeling to Inform Decision Making

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. Using Simulation and Decision Modeling to Inform Decision Making

    2. This Mornings Session Can Clinical Trials really answer all relevant questions? What if the patient is older/younger/sicker/ better/etc. than in the trials? What if the technology has changed? What if management strategy has changed? Can simulation modeling help fill in the gaps?

    3. From the Modelers Side Many decision models in the literature Single use one off models More global natural history models designed for wide range of questions Can decision models inform decisions? Working with the decision makers to determine Relevant alternatives and inputs Relevant outcomes Case study today of working with the US Preventive Services Task Force to examine Cancer Screening

    4. Todays Agenda Diana Petitti, MD, MPH (briefly) Professor of Biomedical Informatics, Arizona State University Vice Chair, USPSTF Author of Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis Ann Zauber, PhD Memorial Sloan-Kettering Cancer Center, NY Coordinator of CISNET Colorectal Cancer Modeling Groups Shalini Kulasingam, PhD University of Minnesota Investigator on the Duke Cervical Cancer Model Diana Petitti

    5. Zauber Kulasingam Petitti

More Related